Monthly Prescribing Reference

Tapinarof Cream Under Review for Plaque Psoriasis

Tapinarof is an investigational, novel, aryl hydrocarbon receptor modulating agent designed as a once-daily, steroid-free topical cream. The Food and Drug Administration (FDA) has accepted for filing ...
Nasdaq

U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of EUCRISA® (Crisaborole) Ointment, 2%, in Children as Young as 3 Months of Age With Mild-to ...

EUCRISA is the first and only 100% steroid-free, topical prescription medication approved for patients as young as 3 months of age in the United States AD is a chronic skin disease characterized by ...
Yahoo Finance

Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5

If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to ...
Business Wire

Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) ...
Healio

Dermavant submits new drug application for tapinarof cream in atopic dermatitis

Please provide your email address to receive an email when new articles are posted on . Tapinarof cream 1% is already approved for treating adults with plaque psoriasis. Treatment led to improved ...
WebMD

Why Eczema Treatments Fail

Eczema treatment doesn’t always work the way you hope it will. Sometimes creams don’t provide enough relief for those itchy, scaly patches on your skin. Steroid creams and ointments of different ...
Business Wire

Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis

LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in ...